Taken together, these studies suggest that DUSP1 and six antagonists are novel anti-neoplasm compounds for cancer treatment, and further understanding their biological functions will help devise more selective inhibitors with improved cellular permeability. This evidence concerns the gene DUSP1 and neoplasm.